# Treatment Options for Facioscapulohumeral Dystrophy
Supportive care
The foundation of treatment consists of measures that address the consequences of muscle fatigue and muscle weakness. This includes physiotherapy and exercise therapy aimed at maintaining mobility and strength. Recent research emphasizes that moderate physical activity is safe and can help maintain muscle function, in contrast to older advice that advocated rest. Ergonomic adjustments at home and at work help conserve energy and reduce the risk of falls and injuries.
For problems with eye closure, eye drops, sunglasses, or in severe cases surgical interventions can help. Sleep problems are sometimes treated with adapted sleeping positions or aids. Psychological support plays a role, as patients with FSHD more frequently report depression and anxiety and sometimes feel socially isolated due to visible muscle weakness in the face and shoulders.
Surgical Interventions
A specific operation is scapulothoracic arthrodesis, in which the scapula (shoulder blade) is surgically fixed to the thorax (rib cage). This is usually performed when shoulder blades are severely weakened and no longer function properly, and is considered in cases of significant limitation and ongoing progression. This can improve arm mobility and relieve pain. The goal is stabilization, not cure.
Eyelid surgery can be performed to better protect the eye when closure no longer works properly.
Medications with Research or Experimental Basis
Corticosteroids ResearchediPositive results in clinical studies, not yet standard treatment
Corticosteroids (cortisone derivatives) have been used and studied in FSHD because they can suppress inflammatory processes. Evidence from clinical studies is mixed: some small studies suggest modest benefit, others do not. They are sometimes considered in cases of rapid progression, but are not listed in all guidelines as standard treatment. Known side effects of long-term use include elevated blood sugar, weakening of bones, insomnia, and increased susceptibility to infection.
DUX4 Repressors ExperimentaliOngoing in study setting, outcome still unknown
DUX4 is a protein that is abnormally produced in FSHD muscle cells and appears to cause the damage. Researchers are trying to identify substances that can suppress the production of DUX4. This is still entirely in the experimental stage; none of these substances are available to patients.
Antisense Oligonucleotides and RNA Therapies ExperimentaliOngoing in study setting, outcome still unknown
These approaches aim to weaken or restore abnormal genetic signals in FSHD cells through customized RNA molecules. Examples from recent clinical studies are AOC 1020 (del-brax) and EPI-321, both of which are in early clinical trials. They are not yet available in routine care. Research focuses on safety and whether they can improve muscle function.
Epigenetic Editing ExperimentaliOngoing in study setting, outcome still unknown
Because FSHD is caused by changes in how genes are read in muscle cells (epigenetics), not by mutations in the DNA itself, researchers are working on "epigenetic editors" — molecules that correct this reading mechanism. This is very recent, supported by artificial intelligence, in preparation for clinical trials.
Mitochondrial and Metabolic Interventions ResearchediPositive results in clinical studies, not yet standard treatment
Because some research suggests that energy failure in muscle cells plays a role, vitamin and nutritional supplements are sometimes considered. Evidence for this is weak. It is regularly monitored whether patients suffer from malnutrition or energy deficiency, especially in later stages.
Genetic Screening and Diagnostics
ProveniIncluded in official guidelines, or approved by EMA or FDA
Accurate genetic and epigenetic analysis (including DNA sequencing and examination of the D4Z4 repeat) is essential for confirming FSHD and distinguishing it from similar muscle diseases. This is standard practice in diagnostics and also helps to inform relatives. Nanoparticle technology and advanced imaging (MRI, ultrasound) are being investigated as tools for early detection of muscle damage and disease progression, but are not yet in standard use.
Monitoring and prognostic tools
ProveniIncluded in official guidelines, or approved by EMA or FDA
Regular physical tests (such as arm strength and walking distance tests) and standardized assessment scales help doctors and patients track progress. Recent research has determined which measurement tools are most useful in clinical practice. This also helps to better design future treatment studies.
---
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._